Virtual Reality Therapy

On November 16, 2021 the U.S. Food and Drug Administration (FDA) announced that it had authorized marketing of EaseVRx, which they described as “a prescription-use immersive virtual reality (VR) system that uses cognitive behavioral therapy and other behavioral methods to help with pain reduction in patients 18 years of age and older with diagnosed chronic lower

Scroll to top